These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36933449)

  • 21. Combination therapy with thymosin alpha1 and dexamethasone helps mice survive sepsis.
    Xiang XS; Li N; Zhao YZ; Li QR; Li JS
    Inflammation; 2014 Apr; 37(2):402-16. PubMed ID: 24122349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection.
    Niles MA; Gogesch P; Kronhart S; Ortega Iannazzo S; Kochs G; Waibler Z; Anzaghe M
    Front Immunol; 2021; 12():647824. PubMed ID: 34122407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.
    Liu F; Wang HM; Wang T; Zhang YM; Zhu X
    BMC Infect Dis; 2016 Sep; 16():488. PubMed ID: 27633969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation.
    Lu RXZ; Lai BFL; Rafatian N; Gustafson D; Campbell SB; Banerjee A; Kozak R; Mossman K; Mubareka S; Howe KL; Fish JE; Radisic M
    Lab Chip; 2022 Mar; 22(6):1171-1186. PubMed ID: 35142777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
    Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
    Front Immunol; 2021; 12():691725. PubMed ID: 34248984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro.
    Matteucci C; Minutolo A; Pollicita M; Balestrieri E; Grelli S; D'Ettorre G; Vullo V; Bucci I; Luchini A; Aquaro S; Sinibaldi-Vallebona P; Macchi B; Perno CF; Mastino A; Garaci E
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S83-100. PubMed ID: 26094546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients.
    Matteucci C; Minutolo A; Balestrieri E; Petrone V; Fanelli M; Malagnino V; Ianetta M; Giovinazzo A; Barreca F; Di Cesare S; De Marco P; Miele MT; Toschi N; Mastino A; Sinibaldi Vallebona P; Bernardini S; Rogliani P; Sarmati L; Andreoni M; Grelli S; Garaci E
    Open Forum Infect Dis; 2021 Jan; 8(1):ofaa588. PubMed ID: 33506065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.
    Li W; Song L; Wu S; Xue X; Zhang L; He L; Han W; Wang Q; Ling R; Zhang W; Yan Z; Zhang Y
    Int J Biol Sci; 2011; 7(5):618-28. PubMed ID: 21647330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in cognitive dysfunction following blast induced traumatic brain injury by thymosin α1 in rats: Involvement of inhibition of tau phosphorylation at the Thr205 epitope.
    Shi QX; Chen B; Nie C; Zhao ZP; Zhang JH; Si SY; Cui SJ; Gu JW
    Brain Res; 2020 Nov; 1747():147038. PubMed ID: 32738231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post-infection and post-vaccination cellular SARS-CoV-2-specific immune response.
    Kratzer B; Schlax LC; Gattinger P; Waidhofer-Söllner P; Trapin D; Tauber PA; Sehgal ANA; Körmöczi U; Rottal A; Feichter M; Oberhofer T; Grabmeier-Pfistershammer K; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Mühl B; Kropfmüller A; Negrin B; Kundi M; Valenta R; Pickl WF
    Allergy; 2022 Nov; 77(11):3408-3425. PubMed ID: 35690994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Glycan Ectodomain of SARS-CoV-2 Spike Protein Modulates Cytokine Production and Expression of CD206 Mannose Receptor in PBMC Cultures of Pre-COVID-19 Healthy Subjects.
    Barbati C; Bromuro C; Vendetti S; Torosantucci A; Cauda R; Cassone A; Palma C
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal cytokine production by circulating monocytes and dendritic cells of myeloid origin in ART-treated HIV-1+ patients relates to CD4+ T-cell recovery and HCV co-infection.
    Almeida M; Cordero M; Almeida J; Orfao A
    Curr HIV Res; 2007 May; 5(3):325-36. PubMed ID: 17504174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection.
    Cords L; Woost R; Kummer S; Brehm TT; Kluge S; Schmiedel S; Jordan S; Lohse AW; Altfeld M; Addo MM; Schulze Zur Wiesch J; Beisel C
    Cytokine; 2023 Feb; 162():156109. PubMed ID: 36529029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients.
    Pontelli MC; Castro ÍA; Martins RB; La Serra L; Veras FP; Nascimento DC; Silva CM; Cardoso RS; Rosales R; Gomes R; Lima TM; Souza JP; Vitti BC; Caetité DB; de Lima MHF; Stumpf SD; Thompson CE; Bloyet LM; Toller-Kawahisa JE; Giannini MC; Bonjorno LP; Lopes MIF; Batah SS; Siyuan L; Luppino-Assad R; Almeida SCL; Oliveira FR; Benatti MN; Pontes LLF; Santana RC; Vilar FC; Auxiliadora-Martins M; Shi PY; Cunha TM; Calado RT; Alves-Filho JC; Zamboni DS; Fabro AT; Louzada-Junior P; Oliveira RDR; Whelan SPJ; Cunha FQ; Arruda E
    J Mol Cell Biol; 2022 Aug; 14(4):. PubMed ID: 35451490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymosin α1 activates complement receptor-mediated phagocytosis in human monocyte-derived macrophages.
    Serafino A; Pica F; Andreola F; Gaziano R; Moroni N; Moroni G; Zonfrillo M; Pierimarchi P; Sinibaldi-Vallebona P; Garaci E
    J Innate Immun; 2014; 6(1):72-88. PubMed ID: 23797159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunopharmacology of thymosin alpha1 and cytokine synergy.
    Naylor PH; Quadrini K; Garaci E; Rasi G; Hadden JW
    Ann N Y Acad Sci; 2007 Sep; 1112():235-44. PubMed ID: 17567942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.
    Albayrak N; Orte Cano C; Karimi S; Dogahe D; Van Praet A; Godefroid A; Del Marmol V; Grimaldi D; Bondue B; Van Vooren JP; Mascart F; Corbière V
    Front Immunol; 2022; 13():769839. PubMed ID: 35422799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.